子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 四氢吡喃衍生物的制备方法 | CN201310552084.5 | 2013-07-26 | CN103664851A | 2014-03-26 | A·巴特尔; M·塞德尔 |
| 本发明涉及2，5-二取代的四氢吡喃衍生物及这些四氢吡喃衍生物前体的制备方法。用于四氢吡喃衍生物的前体是4-戊烯基醇和4-戊烯酸酯，其合适地被取代。 | ||||||
| 2 | Catalysts for hydrodeoxygenation of oxygenated hydrocarbons | US14419395 | 2013-08-15 | US10131604B2 | 2018-11-20 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Michael Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing Group VIII metals. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 3 | Catalysts for hydrodeoxygenation of oxygenated hydrocarbons | US14585852 | 2014-12-30 | US09314778B2 | 2016-04-19 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Mike Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing palladium, molybdenum, tin, and tungsten. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 4 | Glycomimetics As Pseudomonas Aeruginosa Lectin Inhibitors | US14391109 | 2013-04-09 | US20150361122A1 | 2015-12-17 | Alexander Titz |
| The present invention relates to fucose- and mannose-derived glycomimetics and their general use in prophylaxis or treatment of Pseudomonas aeruginosa infections including respiratory tract infections, urinary tract infections, nosocomial infections and chronic wound infections in a patient encompassing a patient suffering already from cystic fibrosis. Said glycomimetics are inhibitors of Pseudomonas aeruginosa lectin LecB. | ||||||
| 5 | Tetrahydropyran compound, liquid crystal composition and liquid crystal display device | US13390930 | 2010-08-10 | US09663716B2 | 2017-05-30 | Tokifumi Masukawa; Kenji Hirata; Junichi Yamashita |
| A compound represented by formula (1-1) or (1-2) is provided. For example, R1 and R2 are independently hydrogen, alkyl having 1 to 10 carbons or alkoxy having 1 to 9 carbons; the ring A1, the ring A2, the ring A3, the ring A4, the ring A5 and the ring A6 are independently 1,4-cyclohexylene or 1,4-phenylene; a, b, c, d, e and f are independently 0 or 1, and the sum of a, b, c, d, e and f is 2; and g, h, i, j, k and l are independently 0 or 1, and the sum of g, h, i, j, k and l is 2. | ||||||
| 6 | CATALYSTS FOR HYDRODEOXYGENATION OF OXYGENATED HYDROCARBONS | US14419395 | 2013-08-15 | US20150183701A1 | 2015-07-02 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Mike Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing Group VIII metals. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 7 | Catalysts for hydrodeoxygenation of oxygenated hydrocarbons | US13586499 | 2012-08-15 | US08946458B2 | 2015-02-03 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Mike Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing palladium, molybdenum, tin, and tungsten. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 8 | Urea and/or thiourea-aldehyde condensation products | US36328064 | 1964-04-28 | US3365468A | 1968-01-23 | HANS FEICHTINGER |
| 9 | テトラヒドロピラン化合物、液晶組成物および液晶表示素子 | JP2011527643 | 2010-08-10 | JPWO2011021534A1 | 2013-01-24 | 解文 益川; 健治 平田; 山下 淳一; 淳一 山下 |
| 大きな負の誘電率異方性を有しかつ、高い透明点と低い粘度を併せ持つのみならず、熱、光などに対する安定性、適切な屈折率異方性、大きな負の誘電率異方性、および他の液晶性化合物との優れた相溶性などの少なくとも1つの特性を有する液晶性化合物を提供する。式(1−1)または(1−2)で表される化合物。例えば、R1およびR2は独立して、水素、炭素数1〜10のアルキル、または炭素数1〜9のアルコキシであり;環A1、環A2、環A3、環A4、環A5および環A6は独立して、1,4−シクロヘキシレンまたは1,4−フェニレンであり、a、b、c、d、eおよびfは独立して0または1であり、a、b、c、d、eおよびfの和は2であり;g、h、i、j、kおよびlは独立して0または1であり、g、h、i、j、kおよびlの和は2である。 | ||||||
| 10 | テトラヒドロピラン化合物、液晶組成物および液晶表示素子 | JP2011527643 | 2010-08-10 | JP5699934B2 | 2015-04-15 | 益川 解文; 平田 健治; 山下 淳一 |
| 11 | TETRAHYDROPYRAN COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY ELEMENTS | EP10809879 | 2010-08-10 | EP2468740A4 | 2015-04-15 | MASUKAWA TOKIFUMI; HIRATA KENJI; YAMASHITA JUNICHI |
| 12 | Glycomimetics as Pseudomonas aeruginosa lectin inhibitors | US14391109 | 2013-04-09 | US09371351B2 | 2016-06-21 | Alexander Titz |
| The present invention relates to fucose- and mannose-derived glycomimetics and their general use in prophylaxis or treatment of Pseudomonas aeruginosa infections including respiratory tract infections, urinary tract infections, nosocomial infections and chronic wound infections in a patient encompassing a patient suffering already from cystic fibrosis. Said glycomimetics are inhibitors of Pseudomonas aeruginosa lectin LecB. | ||||||
| 13 | CATALYSTS FOR HYDRODEOXYGENATION OF OXYGENATED HYDROCARBONS | US14585852 | 2014-12-30 | US20150141667A1 | 2015-05-21 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Mike Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing palladium, molybdenum, tin, and tungsten. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 14 | CATALYSTS FOR HYDRODEOXYGENATION OF OXYGENATED HYDROCARBONS | US13586499 | 2012-08-15 | US20140051872A1 | 2014-02-20 | Brian Blank; Randy Cortright; Taylor Beck; Elizabeth Woods; Mike Jehring |
| The present invention provides catalysts, methods, and reactor systems for converting oxygenated hydrocarbons to oxygenated compounds. The invention includes methods for producing cyclic ethers, monooxygenates, dioxygenates, ketones, aldehydes, carboxylic acids, and alcohols from oxygenated hydrocarbons, such as carbohydrates, sugars, sugar alcohols, sugar degradation products, and the like, using catalysts containing palladium, molybdenum, tin, and tungsten. The oxygenated compounds produced are useful in the production of liquid fuels, chemicals, and other products. | ||||||
| 15 | CATALYSTS AND BORONATE ESTERS | US13412436 | 2012-03-05 | US20120226041A1 | 2012-09-06 | John F. Hartwig; Carl W. Liskey |
| The invention provides catalysts and methods for preparing boronate esters. The methods can include the borylation of a secondary or primary C—H bond, for example, by contacting a reactant having a methylene or methyl and a diboron bis-ester in the presence of an effective catalyst. The contacting can be in the presence of an iridium complex, to effect borylation of the secondary or primary C—H bond, thereby providing the boronate ester. The boronate esters can be readily isolated and/or converted into other useful compounds and intermediates. | ||||||
| 16 | TETRAHYDROPYRAN COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | US13390930 | 2010-08-10 | US20120145958A1 | 2012-06-14 | Tokifumi Masukawa; Kenji Hirata; Junichi Yamashita |
| A compound represented by formula (1-1) or (1-2) is provided. For example, R1 and R2 are independently hydrogen, alkyl having 1 to 10 carbons or alkoxy having 1 to 9 carbons; the ring A1, the ring A2, the ring A3, the ring A4, the ring A5 and the ring A6 are independently 1,4-cyclohexylene or 1,4-phenylene; a, b, c, d, e and f are independently 0 or 1, and the sum of a, b, c, d, e and f is 2; and g, h, i, j, k and l are independently 0 or 1, and the sum of g, h, i, j, k and l is 2. | ||||||
| 17 | TETRAHYDROPYRAN COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY DEVICES | EP10809879.9 | 2010-08-10 | EP2468740B1 | 2017-08-02 | MASUKAWA, Tokifumi; HIRATA, Kenji; YAMASHITA, Junichi |
| 18 | Glycomimetics as pseudomonas Aeruginosa lectin inhibitors | EP12002531.7 | 2012-04-10 | EP2650289B1 | 2016-07-27 | Titz, Alexander, Dr. |
| 19 | Glycomimetics as pseudomonas Aeruginosa lectin inhibitors | EP12002531.7 | 2012-04-10 | EP2650289A1 | 2013-10-16 | Titz, Alexander, Dr. |
The present invention relates to fucose- and mannose-derived glycomimetics and their general use in prophylaxis or treatment of Pseudomonas aeruginosa infections including respiratory tract infections, urinary tract infections, nosocomial infections and chronic wound infections in a patient encompassing a patient suffering already from cystic fibrosis. Said glycomimetics are inhibitors of Pseudomonas aeruginosa lectin LecB. |
||||||
| 20 | TETRAHYDROPYRAN COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND LIQUID CRYSTAL DISPLAY ELEMENTS | EP10809879.9 | 2010-08-10 | EP2468740A1 | 2012-06-27 | MASUKAWA Tokifumi; HIRATA Kenji; YAMASHITA Junichi |
Subject The subject is to provide a liquid crystal compound not only having a large negative dielectric anisotropy, a high clearing point and a low viscosity, but also having at least one of characteristics such as stability to heat, light or the like, a suitable refractive index anisotropy, a large negative dielectric anisotropy and an excellent compatibility with other liquid crystal compounds. Means for Solving the Subject The invention provides a compound represented by formula (1-1) or (1-2).
|
||||||
QQ群二维码
意见反馈
意见反馈